The Valley Desk

Clinical trial reportThe lancet. HIVPublished

Safety, antiviral activity, and pharmacokinetics of long-acting injectable cabotegravir-rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): 48-week results of a multinational, phase 1/2, single-arm study

12 of 31 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, GSK, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
The lancet. HIV
Published
Subject terms
Humans; HIV-1; HIV Infections; Pyridones; Anti-HIV Agents; Treatment Outcome; Viral Load; Injections, Intramuscular; Adolescent; Child; Female; Male
PubMed ID
41547359
PubMed Central ID
PMC13292839
Added to directory
Source checked

Report a correction or request removal